Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of omega-3 polyunsaturated fatty acids on serum albumin in acute heart failure
2015-003048-37Phase 3Active
- Sponsor
- Juan Luis Bonilla Palomas
- Start
- Aug 2015
- Modality
- Small Molecules, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, single-arm trial of Epadel, docosahexaenoic acid and omega-3-acid triglycerides in Acute Heart Failure (AHF), sponsored by Juan Luis Bonilla Palomas. Primary endpoint: Serum albumin levels. Started Aug 2015; status: active.
02
Drugs
Epadeldocosahexaenoic acidomega-3-acid triglycerides
03
Conditions
Acute Heart Failure (AHF)
Beyond the preview
Go deeper on 2015-003048-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003048-37.